CLINICAL_TRIALS
trial_result
· 2017-05-12
Clinical Trial Update: A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder [Phase 2]
Summary
A Phase 2 trial evaluating intranasal ketamine for obsessive-compulsive disorder was terminated; results were posted in May 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mclean Hospital | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: TERMINATED | Results posted: 2017-05-12